The Collaborative Ependymoma Research Network (CERN) Foundation is a nonprofit organization composed of scientists and adult and pediatric cancer researchers who work together to develop new treatments for ependymoma, a type of primary brain or spinal cord tumor that occurs in both children and adults, and improve the outcomes and care of patients.
[4] Shortly thereafter, Gilbert was joined by Richard Gilbertson and Amar Gajjar of St. Jude Children’s Research Hospital, and Ken Aldape and Terri Armstrong of the University of Texas MD Anderson Cancer Center.
After the organization created its initial vision and established its leadership, additional partners joined the CERN team.
[5] On April 19, 2012, the CERN Foundation commemorated the first Ependymoma Awareness Day in Houston with a mass butterfly release.
These institutions are supported by the collaborative efforts of other national and international cancer centers where clinical trials can be accessed.